Satellos Bioscience Inc. (MSLE) income statement
MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.68−0.12 (-2.07%)
Close on Nov 20, 2026Market cap $87.81MP/E –Yield –
Satellos Bioscience Inc. financial ratios
See a number that looks wrong?